Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 1.71% | $392.79M | $526.82B | 48.72% | 78 Outperform | |
| Exxon Mobil | 1.65% | $380.16M | $547.77B | 15.64% | 74 Outperform | |
| Amphenol | 1.64% | $377.89M | $188.98B | 122.40% | 78 Outperform | |
| Merck & Company | 1.63% | $374.14M | $270.12B | 11.14% | 80 Outperform | |
| Chubb | 1.54% | $354.64M | $118.37B | 11.61% | 80 Outperform | |
| Cisco Systems | 1.54% | $353.81M | $297.08B | 24.84% | 77 Outperform | |
| McKesson | 1.52% | $349.14M | $103.74B | 41.83% | 62 Neutral | |
| Cencora | 1.48% | $340.03M | $68.84B | 46.60% | 70 Neutral | |
| Berkshire Hathaway B | 1.47% | $338.83M | $1.06T | 5.42% | 66 Neutral | |
| International Business Machines | 1.43% | $328.94M | $285.72B | 35.98% | 79 Outperform |